Determination of a Threshold Fatal 3-MMC Concentration in Human: Mission Impossible
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Metaphedrone (3-Methylmethcathinone): Pharmacological, Clinical, and Toxicological Profile.
Kelecevic I, Vejnovic A, Javorac J, Gvozdenovic N, Janjic N, Mijatovic Jovin V Medicina (Kaunas). 2024; 60(3).
PMID: 38541192 PMC: 10972361. DOI: 10.3390/medicina60030466.
References
1.
Karila L, Reynaud M
. GHB and synthetic cathinones: clinical effects and potential consequences. Drug Test Anal. 2011; 3(9):552-9.
DOI: 10.1002/dta.210.
View
2.
Sande M
. Characteristics of the use of 3-MMC and other new psychoactive drugs in Slovenia, and the perceived problems experienced by users. Int J Drug Policy. 2015; 27:65-73.
DOI: 10.1016/j.drugpo.2015.03.005.
View
3.
Zaami S, Giorgetti R, Pichini S, Pantano F, Marinelli E, Busardo F
. Synthetic cathinones related fatalities: an update. Eur Rev Med Pharmacol Sci. 2018; 22(1):268-274.
DOI: 10.26355/eurrev_201801_14129.
View
4.
Backberg M, Lindeman E, Beck O, Helander A
. Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clin Toxicol (Phila). 2014; 53(1):46-53.
DOI: 10.3109/15563650.2014.981823.
View
5.
Adamowicz P, Zuba D, Byrska B
. Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB). Forensic Sci Int. 2014; 245:126-32.
DOI: 10.1016/j.forsciint.2014.10.016.
View